![Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/b1cdd688-9db2-471c-a4a1-371fe7e7be5b/gr1_lrg.jpg)
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology
![Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study - ScienceDirect Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356521009113-fx1.jpg)
Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study - ScienceDirect
![Inflammatory Bowel Disease During Childhood Linked to Higher Cancer Rates and Early Death - Drug Discovery and Development Inflammatory Bowel Disease During Childhood Linked to Higher Cancer Rates and Early Death - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/shutterstock_180546590_0.jpg)